Tunable Elastomers with an Antithrombotic Component for Cardiovascular Applications
- 31 May 2018
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 7 (16) , e1800222
Abstract
This study reports the development of a novel family of biodegradable polyurethanes for use as tissue engineered cardiovascular scaffolds or blood‐contacting medical devices. Covalent incorporation of the antiplatelet agent dipyridamole into biodegradable polycaprolactone‐based polyurethanes yields biocompatible materials with improved thromboresistance and tunable mechanical strength and elasticity. Altering the ratio of the dipyridamole to the diisocyanate linking unit and the polycaprolactone macromer enables control over both the drug content and the polymer cross‐link density. Covalent cross‐linking in the materials achieves significant elasticity and a tunable range of elastic moduli similar to that of native cardiovascular tissues. Interestingly, the cross‐link density of the polyurethanes is inversely related to the elastic modulus, an effect attributed to decreasing crystallinity in the more cross‐linked polymers. In vitro characterization shows that the antiplatelet agent is homogeneously distributed in the materials and is released slowly throughout the polymer degradation process. The drug‐containing polyurethanes support endothelial cell and vascular smooth muscle cell proliferation, while demonstrating reduced levels of platelet adhesion and activation, supporting their candidacy as promising substrates for cardiovascular tissue engineering.Keywords
Funding Information
- National Institutes of Health (R01AR057837)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (1U01AR069395)
This publication has 64 references indexed in Scilit:
- Coronary artery bypass grafting hemodynamics and anastomosis design: a biomedical engineering reviewBioMedical Engineering OnLine, 2013
- Fast-degrading elastomer enables rapid remodeling of a cell-free synthetic graft into a neoarteryNature Medicine, 2012
- The Evolution of Vascular Tissue Engineering and Current State of the ArtCells Tissues Organs, 2011
- Mechanical and microstructural properties of polycaprolactone scaffolds with one-dimensional, two-dimensional, and three-dimensional orthogonally oriented porous architectures produced by selective laser sinteringActa Biomaterialia, 2010
- Physiologic compliance in engineered small-diameter arterial constructs based on an elastomeric substrateBiomaterials, 2010
- Amide bands in the IR spectra of urethanesVibrational Spectroscopy, 2009
- FLUID MECHANICS OF ARTIFICIAL HEART VALVESClinical and Experimental Pharmacology and Physiology, 2009
- Development of biodegradable crosslinked urethane-doped polyester elastomersBiomaterials, 2008
- Twenty-Five–Year Experience With the Medtronic-Hall Valve Prosthesis in the Aortic PositionCirculation, 2007
- Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerationsHeart, 2006